HepaTx announces issuance of patent entitled “Methods and Composition for Producing Hepatocyte-Like Cells” in Japan

PALO ALTO, Calif., March 28, 2022 /PRNewswire/ -- HepaTx, a biotechnology company focused on innovative off-the-shelf cell therapies to treat late-stage liver disease, today announced the Decision to Grant Patent protection by the Japanese Patent Office, further strengthening the...

Click to view original post